Navigation Links
InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
Date:2/1/2010

the disease tends to affect slightly more men than women.  There are no medicines approved in the United States or Europe for the treatment of IPF.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology.  InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections.  The pulmonology portfolio includes pirfenidone for which InterMune has completed a Phase 3 program in patients with IPF (CAPACITY) and a New Drug Application (NDA) has been accepted for Priority Review by the FDA.  The hepatology portfolio includes the HCV protease inhibitor compound RG7227 (ITMN-191) that entered Phase 2b in August 2009 and a second-generation HCV protease inhibitor research program.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, which reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated regulatory timelines and the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or informatio
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  Publicis Groupe customer engagement agency Rosetta ... Healthcare Industry Group Leader, has been featured in the ... inspiring people in the life-sciences industry. Those chosen for ... marketing, technology, creativity, strategy and medicine. ... in its leading Rosetta Consulting practice. In 2012, she ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is pleased ... of the first-of-its-kind comic book available in Canada ... been designed specifically to educate children and their parents about ... affecting more than 300,000 Canadians. Eisai is guided ... (hhc) , in which the patient is central – there ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance ... comic series designed to educate children about the most common ... Medikidz Explain Epilepsy comic series tells a fictional ... navigating middle school while living with epilepsy. ... there is still so much misinformation and lack of awareness ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
(Date:8/21/2014)... 21, 2014 The Mount Sinai Hospital ... called RateMyHospital®, which captures real-time patient feedback and enables ... care. The tool, now available to admitted patients in ... feedback regarding patient satisfaction using smartphones. , "We ... it gives us the timely information we need to ...
(Date:8/21/2014)... to a new market report published by Transparency Market ... Size, Share, Growth, Trends and Forecast, 2013 - 2019," ... 1,531.2 million in 2013 and is expected to grow ... to reach an estimated value of USD 5,246.4 million ... witnessing significant growth due to increasing R&D investment in ...
(Date:8/21/2014)... 2014 Entries are now open for ... comprehensive national awards program totally dedicated to recognizing excellence ... executive leadership. The entry deadline is Oct. 17. , ... Insights™, the first and only national magazine entirely devoted ... , “We launched the HREI Insights Awards program last ...
(Date:8/21/2014)... Greater awareness among parents and providers of the ... full term has decreased the practice in the United ... elective deliveries (EEDs) still occur too frequently. A ... as delivery before 39 weeks without medical or obstetrical ... and offers no benefit to mothers or infants. Leading ...
(Date:8/21/2014)... Stevin McNamara’s original approach to guitar music is ... music that has existed in India for centuries. Literally meaning ... scale or some fixed sequence of notes, but is considered ... appropriate time of day or season of the year — ... musician occurs, in its turn creating an unique “sound manifestation” ...
Breaking Medicine News(10 mins):Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 2Health News:The Mount Sinai Hospital Expands Use of Mobile Patient Satisfaction Tool 3Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Global Microfluidic Device System Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 3Health News:Raga Cycle of Shakti Guitar Follows The Sun 2Health News:Raga Cycle of Shakti Guitar Follows The Sun 3
... Minn. -- Over the past few decades, doctors have ... and base of the tongue. Though oral cancer previously ... tobacco and alcohol use, it,s increasing in younger patients: ... Fortunately, the newer form of cancer tends to be ...
... THURSDAY, March 1 (HealthDay News) -- Teens with chronic fatigue ... as joint and muscle pain, may benefit from an Internet-based ... Researchers in the Netherlands studied teens with the debilitating ... better or had recovered after six months of the Web-based ...
... Grafman, PhD, director of Traumatic Brain Injury Research at Kessler ... Brain Injury Conference on March 6, 2012, in Washington, DC. ... consequences of traumatic brain injury. A well known expert, he ... location of brain injury and genetic polymorphisms on social abilities ...
... of death are linked to unhealthy lifestyle behaviors, ... have lower levels of physical activity and higher ... of Health & Human Services. In a new ... adults who received exercise interventions increased their physical ...
... HealthDay Reporter , WEDNESDAY, Feb. 29 (HealthDay News) ... flu and Parkinson,s disease appears to speed recovery in ... Traumatic brain injury (TBI) victims who weren,t fully conscious ... given amantadine hydrochloride. The drug is already given "off-label" ...
... taken by people with HIV/AIDS but long ago shelved after ... on how the human body uses its natural immunity to ... drugs. In an article published online this month by ... Swiss researchers led by scientists at the University of California, ...
Cached Medicine News:Health News:Mayo Clinic: Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer 2Health News:Web-Based Therapy May Help Teens With Chronic Fatigue 2Health News:Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC 2Health News:Fitness programs for minority adults lack cultural relevance, MU study finds 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 2Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 3Health News:Drug Seems to Speed Recovery After Traumatic Brain Injury 4Health News:Old drug reveals new tricks 2Health News:Old drug reveals new tricks 3
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
Demineralized cortical fibers and cancellous chips....
... positioning flexibility while permitting the components to be ... transport. The system has a small footprint to ... the same time offers the surgeon total control ... and display of the Stealthstation Treon can be ...
Medicine Products: